Sarepta Therapeutics
SRPT
SRPT
341 hedge funds and large institutions have $6.47B invested in Sarepta Therapeutics in 2021 Q4 according to their latest regulatory filings, with 73 funds opening new positions, 113 increasing their positions, 97 reducing their positions, and 32 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
12% more funds holding
Funds holding: 305 → 341 (+36)
6% more capital invested
Capital invested by funds: $6.08B → $6.47B (+$394M)
0.22% more ownership
Funds ownership: 82.35% → 82.56% (+0.22%)
Holders
341
Holding in Top 10
5
Calls
$279M
Puts
$192M
Top Buyers
| 1 | +$90.6M | |
| 2 | +$74.8M | |
| 3 | +$72.5M | |
| 4 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$61M |
| 5 |
ACA
Avoro Capital Advisors
New York
|
+$56.3M |
Top Sellers
| 1 | -$235M | |
| 2 | -$113M | |
| 3 | -$62.6M | |
| 4 |
JP Morgan Chase
New York
|
-$41.9M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$41M |